Severe nontuberculous mycobacterial infection in 2 patients receiving rituximab for refractory myositis

J Rheumatol. 2008 Aug;35(8):1683-5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal, Murine-Derived
  • Antibody Formation / drug effects
  • Antirheumatic Agents / therapeutic use
  • B-Lymphocytes / drug effects
  • Female
  • Humans
  • Immunocompromised Host / immunology*
  • Immunologic Factors / adverse effects
  • Immunologic Factors / immunology*
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / immunology*
  • Mycobacterium avium / isolation & purification
  • Mycobacterium kansasii / isolation & purification
  • Myositis / drug therapy*
  • Myositis / immunology
  • Prednisone / therapeutic use
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Immunologic Factors
  • Rituximab
  • Prednisone